3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Stomach Neoplasms
1
Advanced Malignant Solid Tumors
1
Interventions
Oxaliplatin
66
pembrolizumab
47
Fluorouracil
44
Capecitabine
39
Nivolumab
33
Leucovorin
32
Paclitaxel
28
Trastuzumab
20
Docetaxel
19
Cisplatin
18
S 1 (combination)
17
Bevacizumab
15
Irinotecan
14
Drug Therapy
14
tislelizumab
12
Ramucirumab
12
Cyclophosphamide
12
fludarabine
10
Carboplatin
10
sintilimab
9
Radiotherapy
9
Magnetic Resonance Spectroscopy
9
trastuzumab deruxtecan
8
atezolizumab
8
Specimen Handling
8
Biopsy
8
durvalumab
7
Surgical Procedures, Operative
7
Gemcitabine
7
zolbetuximab
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Stomach Neoplasms
×
Premedication
×
1 year
×
Clear all
NCT07245095
2025-11-24
NACSIMET
Hospital General de Mexicali
Phase 2
Recruiting
132 enrolled